Bill McEllen has been a leader in global biopharma commercialization for nearly 30 years. As the global president at Fingerpaint, he serves on the executive leadership team and oversees all of Fingerpaint’s business units. Under his leadership, the agency has experienced exponential growth. His team has garnered 5 Agency of the Year awards in the last 5 years and won a CLIO in a category alongside Nike and Budweiser. Prior to joining Fingerpaint, Bill spent 13 years with McCann Health as president of both McCann Torre Lazur and McCann Echo, where he led his agencies to 14 nominations as Agency of the Year in various industry publications. Bill also spent the first 10 years of his career on the client side in pharma, gaining a deep understanding of the varied challenges our clients face across the full spectrum of commercialization.